Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Chronic Renal Failure

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 60 articles:
HTML format



Single Articles


    July 2020
  1. BAGSHAW SM, Wald R, Adhikari NKJ, Bellomo R, et al
    Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury.
    N Engl J Med. 2020;383:240-251.
    PubMed     Abstract available



  2. Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury.
    N Engl J Med. 2020 Jul 15. doi: 10.1056/NEJMx200016.
    PubMed    


  3. KALANTAR-ZADEH K, Wightman A, Liao S
    Ensuring Choice for People with Kidney Failure - Dialysis, Supportive Care, and Hope.
    N Engl J Med. 2020;383:99.
    PubMed    


  4. KAPLAN JM
    Roxadustat for Anemia in Patients with Chronic Kidney Disease. Reply.
    N Engl J Med. 2020;383:e3.
    PubMed    


  5. XIE J, Chen N
    Roxadustat for Anemia in Patients with Chronic Kidney Disease. Reply.
    N Engl J Med. 2020;383:e3.
    PubMed    


  6. SHAH HH, Fishbane S
    Roxadustat for Anemia in Patients with Chronic Kidney Disease.
    N Engl J Med. 2020;383:e3.
    PubMed    


  7. MOHANDAS R, Segal MS
    Roxadustat for Anemia in Patients with Chronic Kidney Disease.
    N Engl J Med. 2020;383:e3.
    PubMed    


  8. ZIELNIOK K, Burdzinska A, Paczek L
    Roxadustat for Anemia in Patients with Chronic Kidney Disease.
    N Engl J Med. 2020;383:e3.
    PubMed    


  9. ANKER MS, Butler J, Anker SD
    Roxadustat for Anemia in Patients with Chronic Kidney Disease.
    N Engl J Med. 2020;383:e3.
    PubMed    


  10. NISHIOKA R, Kawano M
    Tongue Ulceration from Cytomegalovirus Infection.
    N Engl J Med. 2020;383:67.
    PubMed    


    June 2020
  11. FEIG DI
    Urate-Lowering Therapy and Chronic Kidney Disease Progression.
    N Engl J Med. 2020;382:2567-2568.
    PubMed    


  12. BADVE SV, Pascoe EM, Tiku A, Boudville N, et al
    Effects of Allopurinol on the Progression of Chronic Kidney Disease.
    N Engl J Med. 2020;382:2504-2513.
    PubMed     Abstract available


  13. ANAND S, Staniec A, Montez-Rath M, Vlahos P, et al
    Using GIS Mapping to Track Hot Spots of Kidney Disease in California.
    N Engl J Med. 2020;382:2265-2267.
    PubMed    


    May 2020
  14. FISHBANE S
    Difelikefalin in Hemodialysis Patients with Pruritus. Reply.
    N Engl J Med. 2020;382:2065-2066.
    PubMed    


  15. LIN CH
    Difelikefalin in Hemodialysis Patients with Pruritus.
    N Engl J Med. 2020;382:2064-2065.
    PubMed    


  16. MANENTI L, Rossi GM, Fiaccadori E
    Difelikefalin in Hemodialysis Patients with Pruritus.
    N Engl J Med. 2020;382:2064.
    PubMed    


  17. BRENNAN F, Davison S, Brown M
    Difelikefalin in Hemodialysis Patients with Pruritus.
    N Engl J Med. 2020;382:2064.
    PubMed    


    March 2020
  18. RAMON A, Berthod PE
    Osteitis Fibrosa Cystica.
    N Engl J Med. 2020;382:e15.
    PubMed    


    February 2020
  19. WALSH M, Merkel PA, Peh CA, Szpirt WM, et al
    Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis.
    N Engl J Med. 2020;382:622-631.
    PubMed     Abstract available


    January 2020
  20. BLASI M, Stadtler H, Chang J, Hemmersbach-Miller M, et al
    Detection of Donor's HIV Strain in HIV-Positive Kidney-Transplant Recipient.
    N Engl J Med. 2020;382:195-197.
    PubMed    


    November 2019
  21. FISHBANE S, Jamal A, Munera C, Wen W, et al
    A Phase 3 Trial of Difelikefalin in Hemodialysis Patients with Pruritus.
    N Engl J Med. 2019 Nov 8. doi: 10.1056/NEJMoa1912770.
    PubMed     Abstract available


    October 2019
  22. SELHORST P, Combrinck CE, Manning K, Botha FCJ, et al
    Longer-Term Outcomes of HIV-Positive-to-HIV-Positive Renal Transplantation.
    N Engl J Med. 2019;381:1387-1389.
    PubMed    


    August 2019
  23. JOHNSON RJ, Wesseling C, Newman LS
    Chronic Kidney Disease of Unknown Cause in Agricultural Communities. Reply.
    N Engl J Med. 2019;381:689.
    PubMed    


  24. VIOLO L, De Francesco M, Locatelli F
    Chronic Kidney Disease of Unknown Cause in Agricultural Communities.
    N Engl J Med. 2019;381:688-689.
    PubMed    


  25. CHANG KT, Lin HY
    Chronic Kidney Disease of Unknown Cause in Agricultural Communities.
    N Engl J Med. 2019;381:688.
    PubMed    


  26. BHOWMIK DM
    Chronic Kidney Disease of Unknown Cause in Agricultural Communities.
    N Engl J Med. 2019;381:687-688.
    PubMed    


    July 2019
  27. CHEN N, Hao C, Liu BC, Lin H, et al
    Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis.
    N Engl J Med. 2019 Jul 24. doi: 10.1056/NEJMoa1901713.
    PubMed     Abstract available


  28. CHEN N, Hao C, Peng X, Lin H, et al
    Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis.
    N Engl J Med. 2019 Jul 24. doi: 10.1056/NEJMoa1813599.
    PubMed     Abstract available


  29. KAPLAN J
    Roxadustat and Anemia of Chronic Kidney Disease.
    N Engl J Med. 2019 Jul 24. doi: 10.1056/NEJMe1908978.
    PubMed    


    June 2019
  30. MACDOUGALL IC, Ford I
    Intravenous Iron and Maintenance Hemodialysis. Reply.
    N Engl J Med. 2019;380:e46.
    PubMed    


  31. AFSAR B, Elsurer Afsar R, Kanbay M
    Intravenous Iron and Maintenance Hemodialysis.
    N Engl J Med. 2019;380:e46.
    PubMed    


  32. NAKANISHI T, Kuragano T
    Intravenous Iron and Maintenance Hemodialysis.
    N Engl J Med. 2019;380:e46.
    PubMed    


  33. EISENGA MF, Bakker SJL, Gaillard CAJM
    Intravenous Iron and Maintenance Hemodialysis.
    N Engl J Med. 2019;380:e46.
    PubMed    


  34. AGARWAL R
    Intravenous Iron and Maintenance Hemodialysis.
    N Engl J Med. 2019;380:e46.
    PubMed    


    May 2019
  35. JOHNSON RJ, Wesseling C, Newman LS
    Chronic Kidney Disease of Unknown Cause in Agricultural Communities.
    N Engl J Med. 2019;380:1843-1852.
    PubMed    


    April 2019
  36. INGELFINGER JR, Rosen CJ
    Clinical Credence - SGLT2 Inhibitors, Diabetes, and Chronic Kidney Disease.
    N Engl J Med. 2019 Apr 14. doi: 10.1056/NEJMe1904740.
    PubMed    


  37. PERKOVIC V, Jardine MJ, Neal B, Bompoint S, et al
    Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.
    N Engl J Med. 2019 Apr 14. doi: 10.1056/NEJMoa1811744.
    PubMed     Abstract available


  38. WOJCIECHOWSKI D, Gandhi RT, Rosales IA
    Case 11-2019: A 49-Year-Old Man with HIV Infection and Chronic Kidney Disease.
    N Engl J Med. 2019;380:1464-1472.
    PubMed    


    January 2019

  39. Timing of Renal-Replacement Therapy in Acute Kidney Injury and Sepsis.
    N Engl J Med. 2019;380:398-399.
    PubMed    


  40. XUE C, Zhou C, Xue D
    Timing of Renal-Replacement Therapy in Acute Kidney Injury and Sepsis.
    N Engl J Med. 2019;380:398-9.
    PubMed    



  41. Intravenous Iron in Patients Undergoing Maintenance Hemodialysis.
    N Engl J Med. 2019 Jan 14. doi: 10.1056/NEJMx180044.
    PubMed    


    October 2018
  42. MACDOUGALL IC, White C, Anker SD, Bhandari S, et al
    Intravenous Iron in Patients Undergoing Maintenance Hemodialysis.
    N Engl J Med. 2018 Oct 26. doi: 10.1056/NEJMoa1810742.
    PubMed     Abstract available


  43. BARBAR SD, Clere-Jehl R, Bourredjem A, Hernu R, et al
    Timing of Renal-Replacement Therapy in Patients with Acute Kidney Injury and Sepsis.
    N Engl J Med. 2018;379:1431-1442.
    PubMed     Abstract available


  44. CAULLEY L
    A Seat at the Table.
    N Engl J Med. 2018;379:1400-1401.
    PubMed    


  45. BERNS JS, Glickman A, McCoy MS
    Dialysis-Facility Joint-Venture Ownership - Hidden Conflicts of Interest.
    N Engl J Med. 2018;379:1295-1297.
    PubMed    


    August 2018
  46. MARTINS JM, Magrico R
    Uremic Frost in End-Stage Renal Disease.
    N Engl J Med. 2018;379:669.
    PubMed    


    May 2018
  47. DELMONICO FL
    History of Childhood Kidney Disease and Risk of Adult End-Stage Renal Disease.
    N Engl J Med. 2018;378:1750-1.
    PubMed    


  48. CASTELLANO G, Cravedi P
    History of Childhood Kidney Disease and Risk of Adult End-Stage Renal Disease.
    N Engl J Med. 2018;378:1750.
    PubMed    


  49. KALLEN R
    History of Childhood Kidney Disease and Risk of Adult End-Stage Renal Disease.
    N Engl J Med. 2018;378:1750.
    PubMed    



  50. History of Childhood Kidney Disease and Risk of Adult End-Stage Renal Disease.
    N Engl J Med. 2018;378:1750-1752.
    PubMed    


    February 2018
  51. BERNS JS
    Nutritional Management of Chronic Kidney Disease.
    N Engl J Med. 2018;378:584.
    PubMed    


  52. HOORN EJ, Vogt L, Rotmans JI
    Nutritional Management of Chronic Kidney Disease.
    N Engl J Med. 2018;378:583-4.
    PubMed    


  53. URIBARRI J
    Nutritional Management of Chronic Kidney Disease.
    N Engl J Med. 2018;378:583.
    PubMed    



  54. Nutritional Management of Chronic Kidney Disease.
    N Engl J Med. 2018;378:583-585.
    PubMed    


  55. CALDERON-MARGALIT R, Golan E, Twig G, Leiba A, et al
    History of Childhood Kidney Disease and Risk of Adult End-Stage Renal Disease.
    N Engl J Med. 2018;378:428-438.
    PubMed     Abstract available


    December 2017
  56. COHEN SD, Kopp JB, Kimmel PL
    Kidney Diseases Associated with Human Immunodeficiency Virus Infection.
    N Engl J Med. 2017;377:2363-2374.
    PubMed    


    November 2017
  57. TORRES VE, Chapman AB, Devuyst O, Gansevoort RT, et al
    Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease.
    N Engl J Med. 2017;377:1930-1942.
    PubMed     Abstract available


  58. KALANTAR-ZADEH K, Fouque D
    Nutritional Management of Chronic Kidney Disease.
    N Engl J Med. 2017;377:1765-1776.
    PubMed    


    October 2017
  59. SALY DL, Brewster UC, Sze GK, Louis ED, et al
    An Element of Unsteadiness.
    N Engl J Med. 2017;377:1379-1385.
    PubMed    


    August 2017
  60. MANN JFE, Orsted DD, Brown-Frandsen K, Marso SP, et al
    Liraglutide and Renal Outcomes in Type 2 Diabetes.
    N Engl J Med. 2017;377:839-848.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Renal Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: